Literature DB >> 1552859

Tumour necrosis factor alpha antibody protects against lethal meningococcaemia.

X Nassif1, J C Mathison, E Wolfson, J A Koziol, R J Ulevitch, M So.   

Abstract

Tumour necrosis factor alpha (TNF-alpha) has been shown to be the principal mediator of Gram-negative bacterial endotoxin-induced shock. Nevertheless, evidence suggests that TNF-alpha plays a beneficial role in controlling bacterial infections when multiplication of the microorganism is required to kill the host. Using an infant rat model of Neisseria meningitidis infection, we found that blood TNF-alpha concentration reaches a peak three hours after intraperitoneal injection of 3 x 10(6) bacteria. Thereafter, the level of TNF-alpha decreased and was undetectable six to eight hours after infection. A correlation was observed between the magnitude of initial TNF-alpha response and a fatal outcome. Pretreatment of the animals with polyclonal anti-TNF antiserum significantly reduced mortality relative to animals pretreated with control serum. However, pretreatment of animals with anti-TNF antibody did not alter the bacterial invasion of the cerebrospinal fluid. Injection of heat-killed bacteria did not cause death and induced lower TNF-alpha levels than the same number of live bacteria. This excludes the possibility that the role of TNF-alpha is to mediate a shock induced by the endotoxin component of the bacterial inoculum. These results indicate that TNF-alpha has a deleterious effect in this model of bacteraemia. Identification of the critical factors that determine the action of TNF-alpha during lethal bacteraemia will lead to a better understanding of these diseases and the development of appropriate therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1552859     DOI: 10.1111/j.1365-2958.1992.tb01505.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  10 in total

1.  The outcome of children admitted to intensive care with meningococcal septicaemia.

Authors:  Q Mok; W Butt
Journal:  Intensive Care Med       Date:  1996-03       Impact factor: 17.440

Review 2.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

3.  Neisserial immunoglobulin A1 protease induces specific T-cell responses in humans.

Authors:  Anastasios Tsirpouchtsidis; Robert Hurwitz; Volker Brinkmann; Thomas F Meyer; Gaby Haas
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

4.  Interaction of Neisseria meningitidis with human dendritic cells.

Authors:  A Kolb-Mäurer; A Unkmeir; U Kämmerer; C Hübner; T Leimbach; A Stade; E Kämpgen; M Frosch; G Dietrich
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

Review 5.  Interaction of pathogenic neisseriae with nonphagocytic cells.

Authors:  X Nassif; M So
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

6.  A glycoconjugate vaccine for Neisseria meningitidis induces antibodies in human infants that afford protection against meningococcal bacteremia in a neonate rat challenge model.

Authors:  Kenneth T Mountzouros; Kelly A Belanger; Alan P Howell; Garvin S Bixler; Dace V Madore
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Carcinoembryonic antigen family receptor specificity of Neisseria meningitidis Opa variants influences adherence to and invasion of proinflammatory cytokine-activated endothelial cells.

Authors:  P Muenzner; C Dehio; T Fujiwara; M Achtman; T F Meyer; S D Gray-Owen
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

8.  TNF-α promoter polymorphism: a factor contributing to the different immunological and clinical phenotypes in Japanese encephalitis.

Authors:  Sujit Kumar Pujhari; Radha Kanta Ratho; Sudesh Prabhakar; Baijayantimala Mishra; Manish Modi
Journal:  BMC Infect Dis       Date:  2012-01-26       Impact factor: 3.090

9.  A Neonatal Murine Escherichia coli Sepsis Model Demonstrates That Adjunctive Pentoxifylline Enhances the Ratio of Anti- vs. Pro-inflammatory Cytokines in Blood and Organ Tissues.

Authors:  Esther M Speer; Elizabet Diago-Navarro; Lukasz S Ozog; Mahnoor Raheel; Ofer Levy; Bettina C Fries
Journal:  Front Immunol       Date:  2020-09-23       Impact factor: 7.561

10.  Neisseria meningitidis strains from patients with invasive meningococcal disease differ in stimulation of cytokine production.

Authors:  M Holub; M Scheinostová; O Dzupová; A Fiserová; O Beran; J Kalmusová; M Musilek; P Krízová
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.